Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: A report from the ET-CHD registry, 1997-2006

Journal of Cardiology

Volumn 62, Issue 6, 2013, Pages 354-360

  Li, Yi Hwei ^a   Lin, Gen Min ^a,b   Lin, Chin Lon ^c   Wang, Ji Hung ^c   Chen, Yu Jung ^a,b   Han, Chih Lu ^d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

All cause mortality; Body mass index; Cardiac mortality; Coronary artery disease; Serum uric acid

Indexed keywords

URIC ACID;

ADULT; AGED; ALL CAUSE DEATH; ANGIOGRAPHY; ARTICLE; BODY MASS; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBESITY; REGISTER; RISK ASSESSMENT; TAIWAN; UNDERWEIGHT; URIC ACID BLOOD LEVEL;

ALL-CAUSE MORTALITY; BODY MASS INDEX; CARDIAC MORTALITY; CORONARY ARTERY DISEASE; SERUM URIC ACID;

AGED; BODY MASS INDEX; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; RISK; TAIWAN; URIC ACID;

EID: 84892432066     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.06.002     Document Type: Article

References (33)

1. Rao G.N., Corson M.A., Berk B.C. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 1991, 266:8604-8608.
2. Sato Y., Fujiwara H., Takatsu Y. Biochemical markers in heart failure. J Cardiol 2012, 59:1-7.
3. Kanellis J., Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. J Semin Nephrol 2004, 25:39-42.
4. Messerli F.H., Frohlich E.D., Dreslinski G.R., Suarez D.H., Aristimuno G.G. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980, 93:817-821.
5. Puddu P., Puddu G.M., Cravero E., Vizioli L., Muscari A. The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications. J Cardiol 2012, 59:235-242.
6. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
7. Freedman D.S., Williamson D.F., Gunter E.W., Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995, 14:637-644.
8. Liese A.D., Hense H.W., Lowel H., Doring A., Keil U. Association of serum uric acid with incident myocardial infarction, all cause and CVD mortality in the MONICA Augsburg cohort. Circulation 1998, 97:822. [Abstract].
9. Alderman M.H., Kivlighn S., Beauchard L., Cohen H., Madhavan S. Increased serum uric acid associated with increased cardiovascular disease in treated hypertensive patients. J Hypertens 1998, 16:5. [Abstract].
10. Ward H.J. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998, 352:670-671.
11. Lin G.M., Li Y.H., Zheng N.C., Lai C.P., Lin C.L., Wang J.H., Jaiteh L.E., Han C.L. Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997-2003. J Cardiol 2013, 61:122-127.
12. Lin G.M., Li Y.H., Lin C.L., Wang J.H., Han C.L. Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: A report from the ET-CHD registry. Int J Cardiol 2013, [Epub ahead of print].
13. Oreopoulos A., McAlister F.A., Kalantar-Zadeh K., Padwal R., Ezekowitz J.A., Sharma A.M., Kovesdy C.P., Fonarow G.C., Norris C.M. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J 2009, 30:2584-2592.
14. Angerås O., Albertsson P., Karason K., Råmunddal T., Matejka G., James S., Lagerqvist B., Rosengren A., Omerovic E. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 2013, 34:345-353.
15. Cacoub P.P., Zeymer U., Limbourg T., Baumgartner I., Poldermans D., Röther J., Bhatt D.L., Steg P.G., REACH Registry Investigators Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart 2011, 97:660-667.
16. Kappetein A.P., Feldman T.E., Mack M.J., Morice M.C., Holmes D.R., Ståhle E., Dawkins K.D., Mohr F.W., Serruys P.W., Colombo A. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011, 32:2125-2134.
17. Culleton B.F., Larson M.G., Kannel W.B., Levy Daniel Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
18. Niskanen L.K., Laaksonen D.E., Nyyssönen K., Alfthan G., Lakka H.M., Lakka T.A., Salonen J.T. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
19. Bickel C., Rupprecht H.J., Blankenberg S., Rippin G., Hafner G., Daunhauer A., Hofmann K.P., Meyer J. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002, 89:12-17.
20. Kaya M.G., Uyarel H., Akpek M., Kalay N., Ergelen M., Ayhan E., Isik T., Cicek G., Elcik D., Sahin O., Cosgun S.M., Oguzhan A., Eren M., Gibson C.M. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012, 109:486-491.
21. Spoon D.B., Lerman A., Rule A.D., Prasad A., Lennon R.J., Holmes D.R., Rihal C.S. The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol 2010, 23:277-283.
22. Hillis G.S., Cuthbertson B.H., Gibson P.H., McNeilly J.D., Maclennan G.S., Jeffrey R.R., Buchan K.G., El-Shafei H., Gibson G., Croal B.L. Uric acid levels and outcome from coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009, 138:200-205.
23. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., Mookadam F., Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
24. Carnethon M.R., De Chavez P.J., Biggs M.L., Lewis C.E., Pankow J.S., Bertoni A.G., Golden S.H., Liu K., Mukamal K.J., Campbell-Jenkins B., Dyer A.R. Association of weight status with mortality in adults with incident diabetes. JAMA 2012, 308:581-590.
25. Kalantar-Zadeh K., Block G., Howich T., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439-1444.
26. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81:543-554.
27. Suliman M.E., Johnson R.J., García-López E., Qureshi A.R., Molinaei H., Carrero J.J., Heimbürger O., Bárány P., Axelsson J., Lindholm B., Stenvinkel P. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006, 48:761-771.
28. Hamer M., Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97:2482-2488.
29. Voulgari C., Tentolouris N., Dilaveris P., Tousoulis D., Katsilambros N., Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011, 58:1343-1350.
30. Barter P., McPherson Y.R., Song K., Kesäniemi Y.A., Mahley R., Waeber G., Bersot T., Mooser V., Waterworth D., Grundy S.M. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007, 92:2041-2045.
31. Marroquin O.C., Kip K.E., Kelley D.E., Johnson B.D., Shaw L.J., Bairey Merz C.N., Sharaf B.L., Pepine C.J., Sopko G., Reis S.E., Women's Ischemia Syndrome Evaluation Investigators Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004, 109:714-721.
32. Daly C.A., Hildebrandt P., Bertrand M., Ferrari R., Remme W., Simoons M., Fox K.M., EUROPA Investigators Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial. Heart 2007, 93:1406-1411.
33. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., Rinfret S., Schiffrin E.L., Eisenberg M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.